← Home
/
CG Oncology, Inc. (CGON)
Stock Analysis
CG Oncology, Inc. (CGON)
CGON
CGON · Market data
60.43
+0.25%
Updated: 2026-06-18 13:40 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 61.88. Holding above 53.16 keeps the current thesis intact.
✓
Fundamentals
Strong / Negative
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
53.16
↗
Break Above
Confirmation improves above resistance.
61.88
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 53.16
What's Driving CGON?
📈 Technical recovery is improving
Momentum is Neutral. Watch 61.88 for confirmation and 53.16 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 53.16
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 53.13 and resistance at 61.88. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis. Pattern invalidation sits near 77.77, so a violation there would materially change the current setup narrative.
Business Lens
Long-term structure remains supportive
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
📈 Net Income
-60.20M
↘ Negative
🧮 EPS (Basic)
-0.71
↘ Negative
Note: This is an algorithmic technical snapshot, not financial advice.